Search clinical trials for: Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose

Total 46 results

Giovanni FM Strippoli, MD

Completed

The Clinical Evaluation of the Dose of Erythropoietins Trial (CEDOSE)

Kidney Failure, Chronic

Italy
Pfizer

Completed

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin (AiME - 03)

Chronic Renal Failure Requiring Hemodialysis

United States, Puerto Rico
Hoffmann-La Roche

Completed

A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients

Anemia

France, Germany, Italy, United States, Taiwan, Canada, Puerto Rico, Spain, Thailand, Portugal, United Kingdom, Poland
University of Copenhagen
Rigshospitalet, Denmark

Completed

Renal Effects of Erythropoietin in Humans (EPO 2012)

Renal Effects

Denmark
Pfizer

Completed

A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin (AiME - 04)

Chronic Renal Failure Requiring Hemodialysis

United States
Hamad Medical Corporation

Completed

Comparison Among Erythropoietin Stimulating Agents

Anemia of End Stage Renal Disease

Qatar
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis (EMERALD 2)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

United States, Bulgaria, Romania, United Kingdom, Italy, Poland, France, Germany, Spain
Hoffmann-La Roche

Completed

A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia

Anemia

Belgium, France, Germany, Italy, Spain, United States, Australia, Sweden, Denmark, Taiwan, Greece, Netherlands, United Kingdom, South Africa, Switzerland, Austria, Thailand, Poland, Hungary, Russian Federation, Mexico, Czech Republic and more
Hoffmann-La Roche

Terminated

A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.

Anemia

United States
Julia Xu
Carnegie Mellon University; American Society of Hematology

Recruiting

Hydroxyurea and EPO in Sickle Cell Disease (ACHiEvE-SCD)

Sickle Cell Disease | Anemia, Sickle Cell

United States, Nigeria
Peking University

Unknown

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma | Anemia | Hematopoietic Stem Cell Transplantation

China
Hoffmann-La Roche

Terminated

A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.

Anemia

United States
Hoffmann-La Roche

Completed

(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy

Anemia

Italy, Spain, Mexico, Hungary, Singapore, Greece, United Kingdom, Austria, Thailand, Germany, Poland, Russian Federation, Denmark, Brazil, Sweden, Czech Republic, Finland
Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech Clinical Affairs, L.L.C.

Completed

A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.

Anemia | Renal Failure , Chronic
Hoffmann-La Roche

Terminated

A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

Anemia

Australia
Hoffmann-La Roche

Completed

A Study of NeoRecormon in Patients With Chronic Kidney Disease.

Anemia

Serbia
Hoffmann-La Roche

Completed

A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.

Anemia

Turkey
Hoffmann-La Roche

Completed

A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.

Anemia

Russian Federation
Hoffmann-La Roche

Completed

A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

Anemia

France
Hoffmann-La Roche

Completed

MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia

Anemia

Austria, Switzerland
Hoffmann-La Roche

Completed

A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis (MISTRAL)

Anemia

France
PETHEMA Foundation
Roche Pharma AG; Celgene Corporation

Terminated

SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome (SIMIDIS)

Myelodysplastic Syndrome

Spain
Hoffmann-La Roche

Completed

A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia

Anemia

Morocco
Hoffmann-La Roche

Completed

A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

Chronic Renal Anemia

Greece
Vifor Fresenius Medical Care Renal Pharma
Worldwide Clinical Trials; Fresenius Medical Care Deutschland GmbH

Terminated

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

Anemia | End Stage Renal Disease

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy (Neurepo)

Hypoxic Ischemic Encephalopathy

France
Cinnagen

Completed

Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients

Anemia in End-Stage Renal Disease

Iran, Islamic Republic of
Dong-A ST Co., Ltd.

Unknown

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

Anemia of Chronic Kidney Disease

Turkey
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD

Non-Dialysis-Dependent Chronic Kidney Disease

China
Hoffmann-La Roche

Completed

A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

Anemia

Italy, Spain, France, Canada, Hungary, United States, Germany, Belgium, Poland, Australia, Israel, United Kingdom, Czech Republic
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes | Anemia

United States
M.D. Anderson Cancer Center

Completed

Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS

Myelodysplastic Syndrome

United States
Ain Shams University

Recruiting

Erythropoietin Gel as an Adjunct to Split-Thickness Apically Positioned Flap in Augmentation of Attached Gingiva

Recession | Erythropoietin

Egypt
Merck Sharp & Dohme LLC

Completed

Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)

Hepatitis C, Chronic
Dr. Conrado Fernandez

Completed

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (DARGEN-3)

Chronic Hepatitis C

Spain
Ain Shams University

Not yet recruiting

Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus

Oral Lichen Planus
The First Affiliated Hospital of Soochow University

Not yet recruiting

Decitabine for Poor Graft Function Post Allo-HSCT

Poor Graft Function
Hoffmann-La Roche

Completed

A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Myelodysplastic Syndromes

Spain
University of Cologne

Completed

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Hodgkin´s Lymphoma

Germany
Hospices Civils de Lyon

Unknown

NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels

Chronic Kidney Disease

France
Tanta University

Completed

Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)

Hypoxic Ischemic Encephalopathy

Egypt
Sung Kwang Medical Foundation

Completed

Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy

Cerebral Palsy

Korea, Republic of
The First Affiliated Hospital of Soochow University

Not yet recruiting

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Poor Graft Function
Universitaire Ziekenhuizen KU Leuven

Completed

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)

Reperfusion Injury

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) (CAPITL)

Reperfusion Injury

Belgium
University of Campania "Luigi Vanvitelli"

Completed

Nephropathy In Type 2 Diabetes and Cardio-renal Events (NID-2)

Diabetic Nephropathy

Italy

3

Subscribe